Chargement en cours...

β2-adrenoreceptor medications and risk of Parkinson disease

OBJECTIVE: A recent study observed a two-fold greater risk of Parkinson disease (PD) in relation to the β2-adrenoreceptor antagonist propranolol and a markedly lower risk of PD for the β2-adrenoreceptor agonist salbutamol. We examined whether confounding by clinical indication for these medications,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Neurol
Auteurs principaux: Nielsen, Susan Searles, Gross, Anat, Camacho-Soto, Alejandra, Willis, Allison W., Racette, Brad A.
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6881195/
https://ncbi.nlm.nih.gov/pubmed/30225948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25341
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!